-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SlD3is8KYcSC7+Kz4T1j86trIcXGUKr1jeahaYToNOUavMul+33y/p42pQS1bo/K RQtXC8FN6H15x4zVuTHEqw== 0001239241-05-000009.txt : 20050927 0001239241-05-000009.hdr.sgml : 20050927 20050927165127 ACCESSION NUMBER: 0001239241-05-000009 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050927 FILED AS OF DATE: 20050927 DATE AS OF CHANGE: 20050927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EVNIN ANTHONY B CENTRAL INDEX KEY: 0001239241 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 051105842 MAIL ADDRESS: STREET 1: C/O VENROCK ASSOCIATES STREET 2: 30 ROCKEFELLER PLAZA RM 5508 CITY: NEW YORK STATE: NY ZIP: 21264957 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 BUSINESS ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 3 1 edgar.xml PRIMARY DOCUMENT X0202 3 2005-09-27 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001239241 EVNIN ANTHONY B C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA, ROOM 5508 NEW YORK NY 10112 1 0 0 0 Series A Preferred Stock Common Stock 199363 I By Fund Series A Preferred Stock Common Stock 264272 I By Fund Series B Preferred Stock Common Stock 104538 I By Fund Series B Preferred Stock Common Stock 150433 I By Fund Series B Preferred Stock Common Stock 13420 I By Fund Series C Preferred Stock Common Stock 108129 I By Fund Series C Preferred Stock Common Stock 155600 I By Fund Series C Preferred Stock Common Stock 10989 I By Fund Shares of Preferred Stock are convertible into Common Stock at any time and have no expiration date. All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering. Each share of Series A Preferred Stock will automatically convert into Common Stock on a 1-for-1 basis. Securities held of record by Venrock Associates, a limited partnership of which Anthony B. Evnin is a General Partner. Mr. Evnin disclaims beneficial ownership of these securities except to the extent of his pro-rata interest. Securities held of record by Venrock Associates II, L.P., a limited partnership of which Anthony B. Evnin is a General Partner. Mr. Evnin disclaims beneficial ownership of these securities except to the extent of his pro-rata interest. Each share of Series B Preferred Stock will automatically convert into Common Stock on a 1.087428-for-1 basis. Securities held of record by Venrock Entrepreneurs Fund, L.P., a limited partnership of which Venrock Management LLC is the General Partner. Anthony B. Evnin is a Member of Venrock Management LLC and disclaims beneficial ownership of these securities except to the extent of his pro-rata interest. Each share of Series C Preferred Stock will automatically convert into Common Stock on a 1.972685-for-1 basis. Anthony B. Evnin 2005-09-27 -----END PRIVACY-ENHANCED MESSAGE-----